Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for fragility fracture prevention in hemodialysis
NCT05096195Phase 4Active, not recruiting
- Sponsor
- Western University
- Start
- Jun 2022
- Primary completion
- Dec 2025
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab in fragility fracture, sponsored by Western University. Started Jun 2022; status: active, not recruiting.
02
Drugs
denosumab
03
Conditions
fragility fracture
Beyond the preview
Go deeper on NCT05096195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05096195.